Home  /  East Asia and the Pacific  /  FJI

Fiji

Fiji's Ministry of Health and Medical Services publishes a public HIV surveillance workbook and summary report, giving people newly registered with HIV in every year since 1989, with breakdowns by division, sex and age from 2018. Our project has written the code to read the 2025 workbook and summary report, but the gov.fj government domain gave no network address in any check from 25 to 27 October 2026, and the workbook and summary report could not be downloaded. Fiji therefore appears only through international and donor reporting, and the Fijian figures enter the panel at the first reading after the gov.fj domain returns.

9,100
People living with HIV, 2025
WHO Global Health Observatory
22.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$16k
United States HIV disbursements, 2025
ForeignAssistance.gov
$3k
External HIV financing, all donors, 2023
OECD Creditor Reporting System
External HIV financing
OECD CRS
$0$500k$1m$1.5m20032005200720092011201320152017201920212023$3k
  • All donors
YearAll donors
2003 $142k
2004 $176k
2005 $380k
2006 $343k
2007 $987k
2008 $484k
2009 $549k
2010 $582k
2011 $728k
2012 $1.5m
2013 $999k
2014 $358k
2015 $661k
2016 $542k
2017 $165k
2018 $56k
2019 $18k
2020 $1.1m
2021 $35k
2023 $3k

20 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. Only the OECD CRS record is available for the country, so the two independent records of United States disbursements cannot be compared in the figure.

People living with HIV and people on treatment
UNAIDS AIDSinfo
02.5k5k7.5k2000200320062009201220152018202120245,9001,400
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 100 0 100 —
2001 100 0 100 —
2002 100 0 100 —
2003 100 0 100 —
2004 100 0 100 —
2005 100 0 100 —
2006 100 0 100 —
2007 100 0 200 —
2008 100 0 200 —
2009 100 0 500 —
2010 200 0 500 100
2011 200 0 500 100
2012 500 0 500 200
2013 500 0 550 200
2014 500 0 700 200
2015 640 0 870 500
2016 840 0 1,100 500
2017 1,100 690 1,400 500
2018 1,400 990 1,800 500
2019 1,800 1,400 2,200 500
2020 2,400 1,900 2,900 510
2021 3,000 2,400 3,700 650
2022 3,800 3,000 4,900 570
2023 4,700 3,700 6,400 710
2024 5,900 4,500 8,900 1,400

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%60%2010201220142016201820202022202436.0%24.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 58.0% 58.0%
2011 51.0% 51.0%
2012 62.0% 62.0%
2013 47.0% 47.0%
2014 41.0% 41.0%
2015 33.0% 32.0%
2016 31.0% 26.0%
2017 29.0% 25.0%
2018 28.0% 25.0%
2019 26.0% 24.0%
2020 24.0% 21.0%
2021 24.0% 22.0%
2022 20.0% 15.0%
2023 23.0% 15.0%
2024 36.0% 24.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Fiji

2,619 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,374 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 772 24 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 225 10 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 132 16 2000–2025 extranet.who.int 2026-10-16
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
IATI, through d-portal Expenditure account 27 2 2009–2026 d-portal.org 2026-10-12
OECD Creditor Reporting System Expenditure account 20 1 2003–2023 sdmx.oecd.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 10 10 2016 hivfinancial.unaids.org 2026-10-12
Global Fund Data Service Programme record 4 4 2017 fetch.theglobalfund.org 2026-10-12
ForeignAssistance.gov Expenditure account 2 2 2025 foreignassistance.gov 2026-10-29
UNAIDS Data 2025 country databook Expenditure account 2 2 2016 aidsinfo.unaids.org 2026-10-15

Indicators held

56 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 5 2018–2022 WHO Global Tuberculosis Programme $15k (2022)
Budget required for collaborative TB/HIV activities Financing USD 6 2018–2023 WHO Global Tuberculosis Programme $5k (2023)
Country-reported HIV expenditure, all sources Financing USD 5 2012–2016 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $668k (2016)
Domestic funding received by the national TB programme Financing USD 6 2018–2024 WHO Global Tuberculosis Programme $155k (2024)
Domestic public HIV expenditure Financing USD 2 2016 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $509k (2016)
Expected Global Fund funding for the national TB programme Financing USD 3 2018–2023 WHO Global Tuberculosis Programme $200k (2023)
Expected USAID funding for the national TB programme Financing USD 3 2018–2023 WHO Global Tuberculosis Programme $0 (2023)
Expected domestic funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $177k (2025)
Expected funding for collaborative TB/HIV activities Financing USD 6 2018–2023 WHO Global Tuberculosis Programme $5k (2023)
External HIV financing (all donors, ODA) Financing USD 20 2003–2023 OECD Creditor Reporting System $3k (2023)
External HIV financing from governments other than the United States (IATI) Financing USD 12 2009–2026 IATI, through d-portal $41k (2026)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $999k (2026)
External HIV financing from the United States (ODA) Financing USD 1 2025 ForeignAssistance.gov $16k (2025)
Funding received for collaborative TB/HIV activities Financing USD 5 2018–2022 WHO Global Tuberculosis Programme $15k (2022)
Global Fund funding received by the national TB programme Financing USD 3 2018–2024 WHO Global Tuberculosis Programme $22k (2024)
HIV spending on TB/HIV co-infection Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $10k (2016)
HIV spending on critical enablers Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $10k (2016)
HIV spending on governance and sustainability Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $121k (2016)
HIV spending on prevention Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $294k (2016)
HIV spending on prevention of vertical transmission Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $77k (2016)
HIV spending on treatment, care and support Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $155k (2016)
International HIV expenditure (country-reported) Financing USD 2 2016 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $159k (2016)
Other bilateral HIV expenditure (country-reported) Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $121k (2016)
US HIV disbursements managed by USAID Financing USD 1 2025 ForeignAssistance.gov $16k (2025)
USAID funding received by the national TB programme Financing USD 1 2022 WHO Global Tuberculosis Programme $0 (2022)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 2 2019 UNAIDS AIDSinfo, WHO Global Health Observatory 10.0% (2019)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 22.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 27 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 39.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 19 2003–2024 UNAIDS AIDSinfo 38.7% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 7 2013–2023 UNAIDS AIDSinfo 34.7% (2023)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 5 2013–2022 UNAIDS AIDSinfo 10.1% (2022)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 1 2019 WHO Global Health Observatory 71.0% (2019)
HIV-exposed infants tested within two months of birth Treatment cascade percent 13 2010–2024 UNAIDS AIDSinfo 58.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 11 2015–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 105 (2024)
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 2 2015–2016 UNAIDS AIDSinfo 48.0% (2016)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 2,003 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 30 2010–2024 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 68.0% (2024)
People living with HIV in care screened for TB Treatment cascade count 1 2017 Global Fund Data Service 43 (2017)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 1 2017 Global Fund Data Service 21 (2017)
People newly enrolled on ART during the year Treatment cascade count 7 2013–2023 WHO Global Tuberculosis Programme 173 (2023)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 10 2015–2024 UNAIDS AIDSinfo 88.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 30 2010–2024 UNAIDS AIDSinfo, WHO Global Health Observatory 124 (2024)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 160 (2024)
TB patients with an HIV test result recorded Treatment cascade count 11 2015–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 567 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 500 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 100 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 1.0% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 270 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 1,700 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 9,100 (2025)
Male condoms distributed in a year Prevention and outreach count 1 2022 UNAIDS AIDSinfo 42,218 (2022)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 30 2010–2024 UNAIDS AIDSinfo, WHO Global Health Observatory 200 (2024)
Estimated size of a key population Population denominators count 1 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 933,154 (2025)
Share of HIV-exposed infants who acquire HIV — percent 30 2010–2024 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 24.2% (2024)

Every row shown on the Fiji page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.